[Tumor markers in the diagnosis and follow-up assessment of bronchial carcinoma].
Fischbach
W
W
Medizinische Poliklinik, Universität Würzburg.
D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002283:Carcinoma, Bronchogenic / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D005500:Follow-Up Studies; D006728:Hormones / Q000097:blood; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D010455:Peptides / Q000032:analysis / Q000097:blood; D010751:Phosphopyruvate Hydratase / Q000097:blood; D011379:Prognosis; D015843:Serpins; D019396:Tissue Polypeptide Antigen
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D006728:Hormones; D010455:Peptides; D015843:Serpins; D019396:Tissue Polypeptide Antigen; C051072:squamous cell carcinoma-related antigen; D010751:Phosphopyruvate Hydratase
Tumormarker bei der Diagnostik und Verlaufsbeurteilung von Bronchialkarzinomen.